You are here

  • Home
  • Archive
  • Volume 71, Issue 8
  • Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial

Citation Tools

Article menu
Research letter
Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Fraser JF, Spooner AJ, Dunster KR, et al
Nasal high flow oxygen therapy in patients with COPD reduces respiratory rate and tissue carbon dioxide while increasing tidal and end-expiratory lung volumes: a randomised crossover trial
Thorax 2016;71:759-761.